Regional Account Manager
$174.3k - $225.5k+ Short-term incentives + Long-term incentives
Senior
Bachelor's
New York, NY, USA
RemotePrimarily Upstate NY; field-based with travel up to 75%, including overnight/weekend travel.
Sales & Account ManagementField Sales
About the job
Requirements
- A bachelor's degree is required.
- At least 5 years of pharmaceutical, biotech, or healthcare sales experience is required.
- At least 3 years of rare disease, orphan drug, or highly specialized sales experience is required, including selling high-cost products distributed through specialty pharmacies and requiring extensive coordination with patient services.
- Proven ability to build and execute a comprehensive territory business plan, present territory strategy, address business questions, and take ownership and accountability for territory performance.
- A proven track record of exceeding sales targets and successfully growing and managing a territory in prior roles.
- Previous selling experience in specialized clinics, hospitals, and academic centers, including complete account selling.
- Ability to analyze complex technical data and develop strategic, actionable business plans.
- Strong knowledge of reimbursement, patient access, payer coverage, prior authorization, specialty pharmacy distribution, and related account pull-through in rare disease or specialty markets.
- Strong verbal and written communication skills, including the ability to communicate complex technical information clearly.
- Ability to work independently and collaboratively in a fast-paced, matrixed team environment with internal and external team members.
- Analytical thinking and problem-solving skills, with the ability to adapt to changing priorities and deadlines.
- Planning, organization, and time management skills, including the ability to support and prioritize multiple projects.
- Proficiency with Microsoft Office.
- Ability to travel extensively throughout the assigned territory, including nights and weekends as needed.
- A valid driver's license, personal automobile, and active vehicle insurance policy are required. Must be able to travel daily to and from customer accounts and drive long distances.
- Must meet facility vendor credentialing requirements, which may include training, background checks, and proof of immunization.
Responsibilities
- Represent PTC products to medical professionals specializing in the diagnosis and treatment of metabolic diseases and/or phenylketonuria (PKU) within the assigned region.
- Handle pharmaceutical sales and service operations, including generating sales, communicating and promoting products' clinical and economic benefits, building and maintaining relationships, educating healthcare staff, and identifying opportunities for commercial and scientific growth.
- Work cross-functionally with internal departments and external resources on sales-related issues.
- Support adherence to relevant regulatory requirements and company standard operating procedures.
- Achieve assigned sales targets compliantly and contribute to the success of the metabolism business unit.
- Develop, execute, and continuously refine a strategic business plan for the assigned territory; present territory strategy and performance, respond to business-related questions, and maintain ownership of the territory.
- Implement marketing strategies to meet sales and patient objectives for metabolic and/or PKU products on monthly, quarterly, and yearly bases.
- Collaborate in a matrix environment with Patient Services, Patient Engagement, Marketing, Managed Markets, and Medical Affairs.
- Communicate with internal and external stakeholders and present complex technical and business information verbally and in writing.
- Develop partnerships with targeted physicians and healthcare staff, understand their needs, and discuss how PTC products and resources can meet those needs.
- Identify key treatment centers and facilities, and collaborate across centers and with stakeholders to optimize patient care.
- Establish and maintain relationships with patient and disease-focused advocacy groups.
- Use a consultative, solution-oriented sales approach tailored to healthcare professionals treating patients with metabolic diseases and/or PKU.
- Address and resolve product access and reimbursement issues.
- Cultivate relationships with key thought leaders in the metabolic and/or PKU therapeutic area.
- Perform additional tasks and assignments as specified by management.
Desired Qualifications
- Degrees in life sciences, business, or healthcare are preferred.
- Experience supporting an orphan, rare disease, and/or specialized drug is preferred.
- Experience working in a small, fast-growing, entrepreneurial sales environment is preferred.
- Experience in startup environments and new product launches is preferred.
About the company
PTC Therapeutics is a global biopharmaceutical company that discovers, develops, and markets medicines for rare genetic diseases. It uses RNA biology and post-transcriptional control to create therapies, including small-molecule drugs and gene therapies. Its products include Translarna for nmDMD, Evrysdi for SMA, Emflaza, Upstaza for AADC deficiency, and Kebilidi for CNS indications, all supported by an integrated model from research to commercialization and operations in more than 50 countries with a European base in Dublin. The company aims to provide safe, effective treatments to patients with few or no options by building a strong pipeline and broad global access.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Warren Township, New Jersey
Founded
1998
Get referred to PTC Therapeutics
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue hit $361 million, and management raised 2026 guidance.
- Sephience data on September 25, 2026 reinforced diet liberalization and safety.
- PTC ended Q2 2026 with $2.23 billion cash after 0% notes refinancing.
What critics are saying
- Translarna lost EU authorization in March 2025; FDA withdrawal followed in February 2026.
- Sephience now powers the company; launch failure leaves PTC dependent on fading legacy assets.
- ST-920 faces bankruptcy-court, FDA, and accelerated-approval risk before Q4 2026 submission.
What makes PTC Therapeutics unique
- Sephience reached $151 million Q2 2026 revenue across 1,647 patients globally.
- PTC bought ST-920 on September 21, 2026, adding Fabry gene therapy commercialization.
- PTC's rare-disease commercial machine spans Evrysdi royalties, Sephience launches, and global distribution.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- 401(k) Retirement Plan
- Flexible Work Hours
- Performance Bonus